Nephron SC Recalls Albuterol Sulfate Inhalation Solution
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Nephron SC Recalls Albuterol Sulfate Inhalation Solution
Nephron SC, LLC · Class II — Moderate Risk

Product Description
Albuterol Sulfate Inhalation Solution, 0.5%, 25 mg/5 mL (5 mg/mL*), 30x5 mL Sterile Unit-Dose Vials, Rx only, nephron 503B Outsourcing facility, 4600 12th Street Extension, West Columbia, SC 29172, NDC 69374-330-05.
Reason for Recall
Labelling: Illegible label
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide within the United States
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
Nephron SC, LLC has recalled a pharmaceutical product that the FDA classified as Class II affecting 146,280 vials. The recall was initiated on March 17, 2026. Labelling: Illegible label. It was distributed nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Other Injury Hazards.